The co-stimulatory glucocorticoid-induced TNFR related protein (GITR, also known as TNFRSF18) is a potent target for immunotherapy in mouse models of cancer and chronic infection, owing to its capacity to concurrently promote effector T-cell function and dampen Treg-mediated suppression. This evidence concerns the gene TNFRSF18 and cancer.